For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Monogram Biosciences, Inc.

USPTO Granted Patents = 52

% Expired Patents = 26.9

CIPO Patents = 4

EPO Patents = 15

Trademarks = 11

Forward Citations = 731

Loading Chart...

Loading Chart...

55 inventors (with patents filed for the assignee):

Sharat Singh (19 out of 62 patents)

Neil T Parkin (15 out of 22 patents)

Christos J Petropoulos (13 out of 21 patents)

4. Wei Huang (12 out of 34 patents)

5. Po-Ying Chan-Hui (10 out of 27 patents)

6. Hossein Salimi-Moosavi (9 out of 11 patents)

7. Hrair Kirakossian (8 out of 24 patents)

8. Rajiv Dua (7 out of 13 patents)

9. Sailaja Pidaparthi (7 out of 7 patents)

10. Yining Shi (7 out of 7 patents)

11. Tracy J Matray (5 out of 15 patents)

12. Gerald J Wallweber (4 out of 10 patents)

13. Colombe Chappey (4 out of 4 patents)

14. Jeannette Whitcomb (4 out of 9 patents)

15. Mary T Wrin (4 out of 6 patents)

Core Competencies:

HIV Entry Inhibitors

Viral Resistance

Protein Analysis

Recombinant Virus Assays

Coreceptor Inhibitors

Antiviral Drug Susceptibility

Receptor Complexes

Biomarker Detection

Multiplex Analysis

Protease Inhibitors

Molecular Complexes

Cell Surface Receptors

52 patents: Sort by Forward Citations

1. 11499200 - Methods for determining resistance or susceptibility to HIV entry inhibitors (2022-11-15),

2. 11459624 - Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays (2022-10-04),

3. 10550441 - Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays (2020-02-04),

4. 10416162 - Her2 diagnostic methods (2019-09-17),

5. 10385411 - Methods for determining resistance or susceptibility to HIV entry inhibitors (2019-08-20),

6. 10202658 - Methods for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors (2019-02-12),

7. 10161931 - Methods for determining susceptibility to coreceptor inhibitors (2018-12-25),

8. 9939447 - Methods and compositions for analyzing proteins (2018-04-10),

9. 9841425 - Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays (2017-12-12),

10. 9506121 - Methods for determining resistance or susceptibility to HIV entry inhibitors (2016-11-29),

11. 9493847 - Molecular determinants in the HIV-1 envelope associated with enhanced ability to enter CXCR4-expressing cells (2016-11-15),

12. 9175355 - Methods for determining the presence of antibodies blocking viral infection (2015-11-03),

13. 9110075 - Compositions for analyzing proteins (2015-08-18),

14. 8637252 - Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs (2014-01-28),

15. 8603736 - Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays (2013-12-10),

Company Overview

Monogram Biosciences, Inc., based in South San Francisco, specializes in advanced HIV resistance testing. The company focuses on developing innovative solutions for assessing viral resistance, utilizing technologies such as recombinant virus assays and protein analysis. Their expertise extends to HIV entry inhibitors and coreceptor inhibitors, enabling healthcare providers to evaluate antiviral drug susceptibility effectively. Monogram's commitment to biomarker detection and receptor complexes positions it as a leader in the field of HIV research and diagnostics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

52 Patents

#30 in South San Francisco, CA

#1,589 in California

#6,764 in US

#13,555 in the World

South San Francisco, CA, United States of America

Monogram Biosciences, Inc.

Forward Citations = 731

55 inventors:

Sharat Singh (19 out of 62 patents)

Neil T Parkin (15 out of 22 patents)

Christos J Petropoulos (13 out of 21 patents)

4. Wei Huang (12 out of 34 patents)

5. Po-Ying Chan-Hui (10 out of 27 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Monogram Biosciences, Inc.. Retrieved from https://idiyas.com/company/monogram-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…